BIOG-B:STO
BioGaia
116,80Â SEK
arrow_upward
+1,21%(+1,40) 1J
9 oct., 17:29:57 UTC+2 · SEK
search
Tous les symboles
| Symbole | Cours | Variation | % variat. |
|---|
insights_autoGénération des principaux insights pour BIOG-B...
Ouverture
116,20Â SEK
Élevé
117,90Â SEK
Faible
116,00Â SEK
Cap. boursière
11,50Â Md
Vol. moyen
162,09Â k
Volume
58,09Â k
+Â haut sur 1Â an
136,30Â SEK
+Â bas sur 1Â an
96,20Â SEK
Actions en circulation
98,50Â M
Nombre d'employés
251
Ouverture
116,20Â SEK
Élevé
117,90Â SEK
Faible
116,00Â SEK
Cap. boursière
11,50Â Md
Vol. moyen
162,09Â k
Volume
58,09Â k
+Â haut sur 1Â an
136,30Â SEK
+Â bas sur 1Â an
96,20Â SEK
Actions en circulation
98,50Â M
Nombre d'employés
251
Articles
Sources : Web et partenaires du secteur de l'information
TipRanks
·
il y a 2 jours
BioGaia Sets October 22 Date for Q3 2026 Results and Investor Briefing
Profil
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
À propos de BioGaia